3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Breast Neoplasms
33
Neoplasms
25
Prostatic Neoplasms
16
Colorectal Neoplasms
13
Lung Neoplasms
11
Multiple Myeloma
9
Head and Neck Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Urinary Bladder Neoplasms
5
Hematologic Neoplasms
5
Gastrointestinal Neoplasms
5
Advanced Cancer
5
Uterine Cervical Neoplasms
4
Smoking Cessation
4
Ovarian Neoplasms
4
Melanoma
4
Leukemia
4
Colonic Neoplasms
4
Anxiety Disorders
4
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Recurrence
3
Rectal Neoplasms
3
Neoplasms, Plasma Cell
3
Motor Activity
3
Lymphoma, Follicular
3
Lymphedema
3
Interventions
Voriconazole
4
Caspofungin
4
posaconazole
3
Fluconazole
3
Itraconazole
2
Amphotericin B
2
liposomal amphotericin B
1
Standard of Care
1
ProMune
1
Lymphatic Irradiation
1
Levofloxacin
1
Cyclosporine
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Mycoses
×
Standard of Care
×
Clear all
NCT01254318
2016-11-02
TRAFIC
Merck Sharp & Dohme LLC
Completed
130 enrolled
5 charts